Page last updated: 2024-08-16

resveratrol and Acute Pain

resveratrol has been researched along with Acute Pain in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Aicher, SA; Carroll, JR; Dussor, G; Halls, VS; Hegarty, DM; Nguyen, D; Price, TJ; Robbins, DI1
Asiedu, MN; De Felice, M; Dussor, G; Melemedjian, OK; Price, TJ; Qu, N; Tillu, DV1

Other Studies

2 other study(ies) available for resveratrol and Acute Pain

ArticleYear
Resveratrol increases tear production and ocular pain after corneal abrasion in male, but not female, rats using a photorefractive keratectomy model.
    Experimental eye research, 2022, Volume: 225

    Topics: Acute Pain; Animals; Cornea; Corneal Injuries; Epithelium, Corneal; Lasers, Excimer; Male; Myopia; Photorefractive Keratectomy; Rats; Rats, Sprague-Dawley; Resveratrol

2022
Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain.
    Molecular pain, 2012, Jan-23, Volume: 8

    Topics: Acute Pain; AMP-Activated Protein Kinases; Animals; Chronic Pain; Disease Models, Animal; Dose-Response Relationship, Drug; Eukaryotic Initiation Factor-4F; Extracellular Signal-Regulated MAP Kinases; Hyperalgesia; Interleukin-6; Male; Mice; Mice, Inbred ICR; Pain, Postoperative; Protein Biosynthesis; Resveratrol; Sensory Receptor Cells; Signal Transduction; Sirtuin 1; Stilbenes; Time Factors; TOR Serine-Threonine Kinases; Trigeminal Ganglion

2012